{"id":"W2951229452","doi":"10.1097/01.hs9.0000562388.60660.bc","title":"PS1023 MUTANT IDH1 INHIBITOR IVOSIDENIB (AG‐120) IN COMBINATION WITH AZACITIDINE FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Internal medicine; Gastroenterology; Isocitrate dehydrogenase; IDH1; Adverse effect; Azacitidine; Bone marrow; Nausea; Leukemia; Cytarabine; Chemistry; Mutant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004496636,0.00042699,0.0007930064,0.0002260824,0.00009449516,0.0000636773,0.0002655979,0.0003316994,0.0008314122],"category_scores_gemma":[0.0002069248,0.00035007,0.0001597649,0.0007279498,0.0001243193,0.0003565751,0.0001152112,0.0006785442,0.0004611942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00177939,"about_ca_system_score_gemma":0.001175383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003377185,"about_ca_topic_score_gemma":0.0003921876,"domain_scores_codex":[0.9969063,0.0000750719,0.0005787888,0.0007689355,0.0007842107,0.0008866781],"domain_scores_gemma":[0.9979827,0.0004349686,0.0001774483,0.0007309775,0.000350831,0.0003230051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01600734,0.001742552,0.116394,0.003452912,0.001190452,0.004213228,0.003501923,0.0005686982,0.7460119,0.005841502,0.07150827,0.0295672],"study_design_scores_gemma":[0.1892884,0.01540296,0.07590351,0.005005414,0.0009176434,0.001694784,0.007349467,0.0324975,0.6020924,0.00209683,0.064503,0.003248056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889367,0.000235508,0.0006774535,0.00232959,0.0002152981,0.003743912,0.00005226379,0.0001772318,0.003632046],"genre_scores_gemma":[0.9852428,0.0001549545,0.004613773,0.0006972943,0.000319772,0.0003778259,0.0002748933,0.0001598512,0.008158817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1732811,"threshold_uncertainty_score":0.9998952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01306010377929663,"score_gpt":0.2728298898142398,"score_spread":0.2597697860349432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}